176 related articles for article (PubMed ID: 38263056)
1. Hypoxia upregulating ACSS2 enhances lipid metabolism reprogramming through HMGCS1 mediated PI3K/AKT/mTOR pathway to promote the progression of pancreatic neuroendocrine neoplasms.
Gu D; Ye M; Zhu G; Bai J; Chen J; Yan L; Yu P; Lu F; Hu C; Zhong Y; Liu P; He Q; Tang Q
J Transl Med; 2024 Jan; 22(1):93. PubMed ID: 38263056
[TBL] [Abstract][Full Text] [Related]
2. lncRNA H19 binds VGF and promotes pNEN progression via PI3K/AKT/CREB signaling.
Ji M; Yao Y; Liu A; Shi L; Chen D; Tang L; Yang G; Liang X; Peng J; Shao C
Endocr Relat Cancer; 2019 Jul; 26(7):643-658. PubMed ID: 31117050
[TBL] [Abstract][Full Text] [Related]
3. Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic Cancer.
Zhou Z; Ren Y; Yang J; Liu M; Shi X; Luo W; Fung KM; Xu C; Bronze MS; Zhang Y; Houchen CW; Li M
Gastroenterology; 2022 Nov; 163(5):1281-1293.e1. PubMed ID: 35777482
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-CoA Synthetase 2 Promotes Cell Migration and Invasion of Renal Cell Carcinoma by Upregulating Lysosomal-Associated Membrane Protein 1 Expression.
Yao L; Guo X; Gui Y
Cell Physiol Biochem; 2018; 45(3):984-992. PubMed ID: 29444517
[TBL] [Abstract][Full Text] [Related]
5. ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner.
Chen J; Ye M; Bai J; Gong Z; Yan L; Gu D; Hu C; Lu F; Yu P; Xu L; Wang Y; Tian Y; Tang Q
J Transl Med; 2023 Oct; 21(1):741. PubMed ID: 37858219
[TBL] [Abstract][Full Text] [Related]
6. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
7. STK33 Promotes the Growth and Progression of Human Pancreatic Neuroendocrine Tumour via Activation of the PI3K/AKT/mTOR Pathway.
Zhou B; Xiang J; Zhan C; Liu J; Yan S
Neuroendocrinology; 2020; 110(3-4):307-320. PubMed ID: 31261148
[TBL] [Abstract][Full Text] [Related]
8. Effect of STK3 on proliferation and apoptosis of pancreatic cancer cells via PI3K/AKT/mTOR pathway.
Chen J; Liu F; Wu J; Yang Y; He J; Wu F; Yang K; Li J; Jiang Z; Jiang Z
Cell Signal; 2023 Jun; 106():110642. PubMed ID: 36871796
[TBL] [Abstract][Full Text] [Related]
9. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zhu J; Lv J; Chen J; Zhang X; Ji Y
Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
[No Abstract] [Full Text] [Related]
10. Mitochondrial ribosomal protein L12 potentiates hepatocellular carcinoma by regulating mitochondrial biogenesis and metabolic reprogramming.
Ji X; Yang Z; Li C; Zhu S; Zhang Y; Xue F; Sun S; Fu T; Ding C; Liu Y; Wan Q
Metabolism; 2024 Mar; 152():155761. PubMed ID: 38104924
[TBL] [Abstract][Full Text] [Related]
11. FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β-catenin pathway.
Lu F; Ye M; Hu C; Chen J; Yan L; Gu D; Xu L; Tian Y; Bai J; Tang Q
Cancer Sci; 2023 Sep; 114(9):3553-3567. PubMed ID: 37302809
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
Li Y; Peng F; Tan X; Wang J; Xu Y
Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
14. RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway.
Wei Z; Xia K; Zheng D; Gong C; Guo W
Mol Med; 2023 Oct; 29(1):133. PubMed ID: 37789274
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
16. Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathway.
Ou X; Zhang GT; Xu Z; Chen JS; Xie Y; Liu JK; Liu XP
Pathol Oncol Res; 2019 Apr; 25(2):635-646. PubMed ID: 30411297
[TBL] [Abstract][Full Text] [Related]
17. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
[TBL] [Abstract][Full Text] [Related]
18. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
19. Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1/ChREBP pathway.
Lu J; Li XQ; Chen PP; Zhang JX; Li L; Wang GH; Liu XQ; Jiang CM; Ma KL
Acta Pharmacol Sin; 2024 Feb; 45(2):366-377. PubMed ID: 37770579
[TBL] [Abstract][Full Text] [Related]
20. [P4HA2 promotes occurrence and progression of liver cancer by regulating the PI3K/Akt/mTOR signaling pathway].
Shang L; Jiang W; Zhang J; Wu W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):665-672. PubMed ID: 35673909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
